Early bird pricing opens as the sector prepares for a major new gathering dedicated to healthspan, prevention and the longevity economy.<\/p>\n
The Longevity Show<\/a>, a new two-day event dedicated to healthspan science, clinical innovation and the rapidly expanding longevity economy, has opened ticket sales for its inaugural edition at Tobacco Dock, London, on 26\u201327 June 2026. Positioned as both an industry conference and a public-facing experience, the Show aims to convene stakeholders from across the ecosystem \u2013 clinicians, researchers, entrepreneurs, policymakers and health-conscious consumers \u2013 at a moment when interest in prevention and healthy aging is accelerating globally.<\/p>\n Early bird pricing<\/a> has now gone live, with the Discover, Experience and VIP tiers available at reduced rates until 28 February 2026. Business-focused passes and Business VIP options sit alongside consumer tickets, reflecting the Show\u2019s dual remit: to explore the commercial landscape of longevity while engaging individuals eager to put longevity science into practice. According to cofounder Phil Newman: \u201cLongevity is entering its most exciting phase; more people than ever want to understand what the science means for their own healthspan, while industry leaders are recognizing the size of the opportunity ahead. The Longevity Show brings these worlds together in one place.\u201d<\/p>\n Longevity.Technology: The scale and ambition of the Longevity Show demonstrate that longevity has matured into a cultural and commercial force in its own right; not so long ago the field occupied a handful of specialist conferences and more than a little skepticism, yet here we are with a program that spans consumer behavior, translational science, clinical models and the business of prevention. It signals that longevity has become substantial enough, and sufficiently interdisciplinary, to merit its own ecosystem rather than borrowing corners of everyone else\u2019s. The Show\u2019s dual-track architecture \u2013 one foot in geroscience and clinical innovation, the other in consumer adoption and everyday health optimization \u2013 reflects a field that is not only expanding but cohering, drawing its constituencies into a shared conversation about prevention, performance and the realities of aging well. Crucially, it marks a shift from isolated interventions to an appreciation of how different strands of science and practice interlock.<\/p>\n What stands out is the timing; the field has stopped waiting for \u201cthe moment\u201d and appears to have quietly crossed into it. Biomarkers are edging toward everyday use, clinics are professionalizing, investors are taking a longer-term view and the public is rather more informed than many expected. Bringing these groups together under one roof is not just a logistical achievement but a reminder that longevity\u2019s centre of gravity is widening \u2013 and, if we are honest, that the sector is learning to talk to itself more coherently. The implication is hard to miss: prevention is moving from aspiration to infrastructure, and society will soon have to decide whether it wishes to keep pace or be pulled along by it.<\/p>\n Industry conference and consumer experience<\/p>\n The Show, which is jointly owned by\u00a0Founders Forum<\/a>\u00a0and\u00a0Longevity.Technology<\/a>, will run two parallel programs: an industry conference designed for business leaders, investors and healthcare organisations, and a consumer-focused experience for individuals interested in improving their healthspan. The industry conference will explore the longevity economy\u2019s emerging contours, examining how insurance, real estate, consumer health, digital innovation and clinic models are adapting to longer lives and increased demand for preventive care. Draft sessions include discussions on the future of diagnostics, the economics of extended vitality, AI-enabled clinical pathways and the evolution of longevity clinics from boutique enterprises to scalable networks. <\/p>\n For consumers, the program offers an accessible yet scientifically rooted introduction to the tools, habits and technologies shaping everyday longevity. Sessions will range from nutrition and metabolic health to sleep, cognition, diagnostics and digital tools, complemented by workshops that provide practical, hands-on insight into techniques from breathwork to behavioral change. The Discover Stage will showcase innovations in diagnostics, performance technologies and metabolic monitoring, giving attendees the opportunity to engage directly with products and approaches gaining traction in the field.<\/p>\n Early bird tickets and practical details<\/p>\n Three main ticket tiers \u2013 Discover, Experience and VIP \u2013 are available for the consumer-facing program, each offering different levels of access across expo areas, public stages, workshops and after-hours events. On the industry side, Business and Business VIP passes provide entry to conference sessions, networking lounges, food and beverage offerings and exclusive registration lines. Early bird pricing reduces the cost of all categories until 28 February 2026, with consumer tickets starting at \u00a379 + VAT and industry passes from \u00a31,299 + VAT.<\/p>\n Newman notes that the early interest suggests a growing appetite for a comprehensive event in this space. \u201cThe longevity industry is reaching peak hype,\u201d he says. \u201cWe want attendees to leave with a clearer understanding of the longevity landscape, whether they\u2019re building companies, delivering care or simply taking ownership of their own healthspan.\u201d<\/p>\n A shift in the conversation<\/p>\n The arrival of the Longevity Show marks a moment in which prevention and healthspan \u2013 once niche concerns \u2013 are moving closer to the centre of public and commercial discourse. As the boundaries between scientific discovery, clinical deployment and personal health management continue to blur, gatherings of this kind may become essential for helping the sector define its next decade. The Show\u2019s debut is a timely reflection of a field no longer content to sit at the margins, but one that is consolidating its ideas and ambitions, placing longevity firmly within the emerging architecture of future health systems.<\/p>\n